Upcoming MDPI Conferences (0)No conferences found for the selection.
Brain Sciences announces selected third-party conferences. In case you would like to announce your own event on the Brain Sciences website, please fill out the following form to apply for the announcement of a conference or other academic event (seminar, workshop).
Upcoming Partner Conferences (1)
10–13 December 2023 Psychedelic Medicine—Israel 2023
Tel Aviv, Israel
A palpable atmosphere of excitement and innovation pervades the field of psychedelic medicine as more and more clinical and preclinical researchers take up the challenge in addition to the nascent psychedelic drug development industry growing by leaps and bounds. Most remarkably, therapeutic developments are bringing together psychotherapy and psychopharmacology even as the debate intensifies as to whether the perceptual effects of psychedelics are necessary for their therapeutic action.
The potential impact of psychedelics is not limited to psychiatry. Fields such as neurology, palliative care, addiction, and pain medicine are among the potential beneficiaries, along with inflammatory and possibly autoimmune disorders. Anecdotal and uncontrolled reports of efficacy still outnumber randomized controlled trials, but the gap is narrowing as state-of-the-art studies are published in the most influential journals. What is remarkable is that the field enjoys an unbounded supply of mostly untapped and unstudied entheogens, many of which have a long history as folk treatments, some almost since the dawn of time.
These exciting times for psychedelic medicine warrant a unique international conference. Psychedelic Medicine—Israel 2023 will provide a truly interdisciplinary international forum for exchanging ideas, unveiling innovations, and training in the basics of psychedelic-assisted psychotherapy. The conference will encompass basic, translational, and clinical research. A richly varied program will include plenary lectures, thematic symposia, poster sessions, workshops, and informal salons for discussion and interaction. The participation of students and trainees will be encouraged via Young Investigator Stipends that will be open for worldwide application. The participation of the highly innovative psychedelic drug development sector is fostered and encouraged. We look forward to the support of the industry to allow the conference to attain its scientific and educational goals.